Home2315 • HKG
add
Biocytogen Pharmaceuticals Beijng Co Ltd
Nakaraang pagsara
$15.58
Sakop ng araw
$15.00 - $15.80
Sakop ng taon
$5.60 - $17.30
Market cap
6.04B HKD
Average na Volume
176.22K
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(CNY) | Hun 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 205.25M | 25.60% |
Gastos sa pagpapatakbo | 152.22M | -22.45% |
Net na kita | -25.34M | 73.30% |
Net profit margin | -12.34 | 78.75% |
Kita sa bawat share | — | — |
EBITDA | 46.50M | 228.84% |
Aktuwal na % ng binabayarang buwis | -7.64% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(CNY) | Hun 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 424.07M | -25.45% |
Kabuuang asset | 2.43B | -10.51% |
Kabuuang sagutin | 1.69B | -3.70% |
Kabuuang equity | 744.24M | — |
Natitirang share | 399.40M | — |
Presyo para makapag-book | 8.42 | — |
Return on assets | 0.39% | — |
Return on capital | 0.71% | — |
Cash Flow
Net change in cash
(CNY) | Hun 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | -25.34M | 73.30% |
Cash mula sa mga operasyon | 14.80M | 268.52% |
Cash mula sa pag-invest | -15.98M | 64.49% |
Cash mula sa financing | -6.73M | -162.60% |
Net change in cash | -6.88M | 81.93% |
Malayang cash flow | 19.94M | 133.06% |
Tungkol
Itinatag
Nob 13, 2009
Website
Mga Empleyado
1,040